Streetbeat News

Products Services

TNON

Tenon Medical has announced expanded physician use of its new JIB Instrument Kit for the company's Catamaran SI Joint Fusion System. The JIB Kit is a next-generation instrument set used to implant the Catamaran Fixation Device during an SI Joint fusion procedure.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 12:16 pm

GOOG

HLIT

Harmonic has announced collaborations with Google and Equativ to expand its ad tech ecosystem and enhance video streaming monetization.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 12:15 pm

AAPL

ERIC

SSNLF

XIACF

XIACY

Huawei Technologies has reached a global patent cross-licensing deal with Xiaomi Corp, resolving a patent licensing dispute between the two. The deal covers communication technologies, including 5G. Huawei also has patent license agreements with Oppo, Samsung Electronics, and Ericsson. Meanwhile, Apple has reduced the prices for its iPhone 14 series in China following the launch of the iPhone 15 lineup. Morgan Stanley does not see Huawei's re-emergence into the 5G smartphone market as a threat to Apple.

Portfolio Pulse from Anusuya Lahiri

September 13, 2023 | 12:14 pm

FXI

UCAR

U Power Limited plans to deliver its second UOTTA battery-swapping station for electric taxis in Anji County, Zhejiang Province, China by October 2023.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 12:12 pm

CVS

CVS Health has announced that the recently approved updated Covid-19 vaccine is now available at CVS Pharmacy locations. The pharmacies will start receiving the new vaccine today and all CVS Pharmacy locations are expected to have the vaccination in stock by early next week.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 12:10 pm

ORCL

Bahraini telecom leader Batelco is accelerating its cloud-first journey with Oracle (ORCL). The partnership aims to fuel growth and provide exceptional customer experiences through new service innovation.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 12:09 pm

HZNP

Q32 Bio and Horizon Therapeutics have dosed the first patient in a Phase 2 study of bempikibart in adult patients with severe alopecia areata. The companies are collaborating to develop bempikibart, an anti-IL-7Rα antibody that re-regulates adaptive immune function.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 12:08 pm

HON

Honeywell Automation and Digitalization Technologies will provide support to American Battery Factory's new Gigafactory. The partnership will leverage Honeywell's automation and digitalization solutions to enhance the factory's operations.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 12:08 pm

RGLS

Regulus Therapeutics has completed enrollment in the second cohort of its Phase 1b multiple-ascending dose clinical trial of RGLS8429 for the treatment of patients with Autosomal Dominant Polycystic Kidney Disease.

Portfolio Pulse from Bill Haddad

September 13, 2023 | 12:06 pm